Job Description
AstraZeneca continues to pursue value enhancing transaction opportunities to supplement its product portfolio and development pipeline. In addition, AstraZeneca wishes to deliver maximum value from existing assets and is keen to pursue appropriate partnerships, collaborations, out-licenses and divestments that will create value and/or share risk. AstraZeneca Business Development is a globally integrated organisation with world class capabilities in strategic planning, search & evaluation, transaction execution and alliance & integration management. The nature of Business Development work is varied, fast moving and unpredictable. As such Business Development provides challenging and varied opportunities for professional and personal development and an unrivalled opportunity to ‘make a difference’ to the future of the Company. Deal Finance is responsible for leading the financial aspects of Business Development and M&A projects within AstraZeneca, including valuation, financial analysis and deal structuring. In addition, Deal Finance provide dedicated support in the negotiation and execution of transactions. As a key member of Deal Finance, the Associate Director will provide dedicated financial support in evaluating and executing M&A, licensing, spin-out, collaboration and other structured transaction opportunities within AstraZeneca globally. The role would ideally suit a candidate with an interest in the broader Pharmaceutical industry and thrives on delivering in a fast-paced work environment.
Responsibilities + Skills
Confident and clear presenter, who can communicate financial recommendations in a concise and impactful manner to both financial and non-financial audiences.Well-developed influencing skills. Experience of F2F negotiations in international environment an advantage.
Education
Experience
Expertise in core financial evaluation techniques and financial modelling / strong excel capabilityWorking knowledge of technical accounting to support efficient deal structuring and simulate of the financial statement impact of transaction alternatives. Forecasting / forecast analysis experience in commercial and or R&D sector is a plus